<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910306648-aegis-treatment-centers-launches-mobile-medication-vehicle-to-expand-access-to-addiction-care-in-pasadena-and-surrounding-areas</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:45:00+00:00</news:publication_date>
        <news:title>Aegis Treatment Centers Launches Mobile Medication Vehicle to Expand Access to Addiction Care in Pasadena and Surrounding Areas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTNhY2M2NTAtZDZhMy00MDM4LWJmMjEtYzhiYzkwOGIwMDcyLTEyNzQyMTYtMjAyNi0wNS0wNC1lbg==/tiny/Pinnacle-Treatment-Centers.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910291496-sync-supplement-claims-evaluated-the-revive-daily-sunlight-loophole-formula-for-healthy-circadian-rhythm-support</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:18:28+00:00</news:publication_date>
        <news:title>SYNC Supplement Claims Evaluated: The Revive Daily Sunlight Loophole Formula for Healthy Circadian-Rhythm Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/05/SYNC-Supplement.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910291435-sace-launches-out-in-the-open-campaign-for-sexual-violence-awareness-month</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:10:11+00:00</news:publication_date>
        <news:title>SACE Launches “Out in the Open” Campaign for Sexual Violence Awareness Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2ZhZGI5YjgtZTI2NS00NmY1LTgzYTEtMmFhMTZmNzI3YmM3LTUwMDE2MjA1My0yMDI2LTA1LTA0LWVu/tiny/Sexual-Assault-Center-of-Edmon.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910291473-eascra-biotech-welcomes-dr-anne-yau-as-life-science-research-scientist</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:04:04+00:00</news:publication_date>
        <news:title>Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1eda41c1-8c5d-43f0-9198-b0a1570f47e6/medium/dr-anne-yau.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910278476-confluent-medical-technologies-announces-nitinol-wire-center-of-excellence</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Confluent Medical Technologies Announces Nitinol Wire Center of Excellence</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/028bf7c1-4bf6-4b3b-8629-3235829b9477/small/confluent-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910272567-when-the-heart-can-t-keep-up-what-to-know-about-heart-failure</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:28:08+00:00</news:publication_date>
        <news:title>When the Heart Can’t Keep Up: What to Know About Heart Failure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/79158b1b-2b4f-4818-8faa-7574106d7290/17877-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910272536-timelycare-acquires-alongside-to-expand-continuous-student-support-with-clinician-powered-ai-coaching</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:00:00+00:00</news:publication_date>
        <news:title>TimelyCare Acquires Alongside to Expand Continuous Student Support with Clinician-Powered AI Coaching</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/51377623-fd82-411b-9c2c-22d85af45622/medium/alongside-by-timelycare.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910272574-awareness-is-key-3-steps-to-help-recognize-stroke-signs-and-risks-for-better-outcomes</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:59:07+00:00</news:publication_date>
        <news:title>Awareness is Key: 3 Steps to Help Recognize Stroke Signs and Risks for Better Outcomes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/71a30026-5d47-467d-b6d5-c5bf1d2b31d8/17855-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910266581-flyte-increases-capacity-and-launches-hiring-initiative-as-spirit-airlines-shutdown-disrupts-u-s-air-travel</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:30:00+00:00</news:publication_date>
        <news:title>Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910266602-chopped-leaf-launches-new-premium-sandwich-lineup-featuring-toasted-ciabatta-creations</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:24:08+00:00</news:publication_date>
        <news:title>Chopped Leaf Launches New Premium Sandwich Lineup Featuring Toasted Ciabatta Creations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZGY0ZWI1OTEtNGNhNy00ZmFjLThhN2EtODM5YTdmNmVkMDUxLTEyNzIxMjEtMjAyNi0wNS0wNC1lbg==/tiny/The-Chopped-Leaf.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910262632-mmi-s-symani-surgical-system-treats-first-alzheimer-s-patient-in-groundbreaking-remind-study</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:10:00+00:00</news:publication_date>
        <news:title>MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9325bed-8fcb-4abf-b66e-6f076014b0fb/small/mmi-logo-stacked-tagline-positive-rgb1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910262611-research-on-new-class-of-treatments-for-ovarian-cancer-receives-725-000-in-funding-from-ovarian-cancer-canada-to-become-clinical-trial-ready</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWY2NGZiYWEtODcyZC00Y2I5LThkZGEtYmM5ZjlkYzFkNDMzLTEzMTI5NjUtMjAyNi0wNS0wNC1lbg==/tiny/Ovarian-Cancer-Canada.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910262626-spring-allergies-hit-lungs-hard-doctor-of-pharmacy-explains-what-actually-helps</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/13a92186-d8d0-4494-9e0a-5fc1d2e363ee/small/betterbrand-logo-new-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910262571-xpress-wellness-acquires-wichita-s-mental-health-clinic-midwest-counseling-services</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:57:00+00:00</news:publication_date>
        <news:title>Xpress Wellness Acquires Wichita’s Mental Health Clinic Midwest Counseling Services</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3c8097b3-a387-4dd0-8063-4f48aad75699/small/xpress-wellness-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910258243-cdc-host-tt-certification-for-siemens-healthineers-total-testosterone-test-expands-patient-access-to-gold-standard-equivalent-results</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>CDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c5f289d1-b23c-41d2-bfe1-0121523d54b6/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910258255-coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910258286-alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:17:21+00:00</news:publication_date>
        <news:title>Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910253033-greece-launches-world-s-first-national-wildfire-satellite-system-with-ororatech</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:04:00+00:00</news:publication_date>
        <news:title>Greece Launches World’s First National Wildfire Satellite System with OroraTech</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f405d4dd-2633-4e23-8086-bbaa6bf83b25/medium/ororatech-s-hellenic-fire-system.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910253114-aura-biosciences-announces-pricing-of-260-million-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:03:06+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910252862-carnosyn-brands-expands-tribsyn-applications-across-beverage-dairy-and-medical-nutrition</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910252869-oncolytics-biotech-reports-durable-responses-in-second-line-ras-mutant-mss-colorectal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910252878-curated-digital-health-works-now-there-s-a-claims-study-to-prove-it</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Curated Digital Health Works; Now There’s a Claims Study to Prove It</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8d88974-2aeb-4baa-ad3b-2ab758ed4dd9/small/solera-main-logo-red-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910252958-biomogging-brings-research-backed-rigour-to-looksmaxxing-as-the-discipline-goes-mainstream</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>BioMogging Brings Research-Backed Rigour to Looksmaxxing as the Discipline Goes Mainstream</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/70c5dbfa-bae7-4e93-ac79-cd20cb471a59/medium/biomogging-brings-research-backed-rigour-to-looksmaxxing-as.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910252971-fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910253043-gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:47:47+00:00</news:publication_date>
        <news:title>Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910252933-cannabix-technologies-announces-delivery-of-marijuana-breath-test-mbt-to-workplace-drug-and-alcohol-testing-clinic</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:45:00+00:00</news:publication_date>
        <news:title>Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72457dcd-4783-441b-b82d-641591cd1f13/medium/cannabix-technologies-inc.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910253010-polyrizon-announces-u-s-patent-expansion-for-its-intranasal-drug-delivery-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:45:00+00:00</news:publication_date>
        <news:title>Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWIxMzIzNDgtN2UwNy00NTAyLThjZDMtZWMwNGFjZTdmNWJhLTUwMDEyOTIyMy0yMDI2LTA1LTA0LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247536-brainway-launches-personalized-anti-procrastination-app-grounded-in-cbt-earns-6-000-user-reviews</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/59f7037f-6f10-4f4b-9b8f-6a7b25f61828/medium/brainway-smarter-focus-built-around-you.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247553-mapi-pharma-explores-u-s-aseptic-manufacturing-facility-to-support-growing-demand-for-aseptic-and-long-acting-generic-and-innovative-injectables</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247597-abeona-therapeutics-announces-date-of-first-quarter-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Date of First Quarter Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247598-sienna-continues-platform-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Sienna Continues Platform Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247606-dentsply-sirona-launches-smart-view-detect-world-s-first-fda-cleared-ai-enabled-diagnostic-aid-for-detecting-teeth-with-periapical-radiolucencies</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247610-fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247613-bicara-therapeutics-to-report-first-quarter-2026-financial-results-and-business-updates-on-may-11-2026-at-8-30-am-et</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247630-fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910247674-newgen-provides-update-on-fiscal-year-2025-results-and-strategic-progress</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZWQwY2VjNmQtYTdlZi00YTUxLTg3NmItMmI3OWVkMTQ5MGQ4LTEyOTcwMTEtMjAyNi0wNS0wNC1lbg==/tiny/NewGenIvf-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242525-serefin-health-launches-mycaresteps-program-to-support-care-coordination-across-grey-bruce</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:05:00+00:00</news:publication_date>
        <news:title>Serefin Health Launches MyCareSteps Program to Support Care Coordination Across Grey Bruce</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NmJiMmQwN2MtYTlmMi00Njc1LTk1N2QtNmZlYzk1MDJkMTc3LTEzMjMwMzktMjAyNi0wNS0wNC1lbg==/tiny/Serefin-Inc.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:05:00+00:00</news:publication_date>
        <news:title>Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>4DMT to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242492-nanox-announces-distribution-agreement-with-nuviodx-to-support-deployment-of-nanox-arc-systems</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242493-bascom-palmer-eye-institute-presents-four-posters-on-rose-bengal-photodynamic-antimicrobial-therapy-at-arvo-2026-advancing-the-clinical-case-for</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Bascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus’s VisiRose Subsidiary and Rose Bengal Sodium in Infectious Keratitis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7cd1d796-f4d3-43f7-8e2b-eb51dc04a073/small/new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242515-healthlynked-launches-new-consumer-platform-and-multi-site-digital-ecosystem-to-redefine-the-front-door-to-healthcare</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>HealthLynked Launches New Consumer Platform and Multi-Site Digital Ecosystem to Redefine the Front Door to Healthcare</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d46cdad7-4537-49b8-bd75-54331ac4ff32/small/get-better-faster-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242561-lenz-therapeutics-to-report-first-quarter-2026-financial-results-and-recent-corporate-highlights-on-may-11-2026-and-attend-upcoming-investor</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e058841a-d17f-4fd7-b817-0b2c8e6cb656/small/lenz-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242578-akebia-therapeutics-announces-vadadustat-post-hoc-win-statistics-analysis-demonstrating-statistically-significant-reduction-in-mortality-and</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910242619-senseonics-enters-into-amended-loan-agreement-with-hercules-to-increase-borrowing-capacity-to-140-million</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237928-emerging-drugs-market-to-reach-558-0-billion-by-2030-driven-by-biologics-innovation-and-regulatory-support</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:34:01+00:00</news:publication_date>
        <news:title>Emerging Drugs Market to Reach $558.0 Billion by 2030, Driven by Biologics Innovation and Regulatory Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237828-vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b5c9081c-e6d9-44f7-abd0-0997a3c713f2/small/vera-thumbnail-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237835-entente-education-canada-honours-dr-roger-wong-with-award-for-eminent-contribution-to-older-adults-in-canada</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Entente Education Canada honours Dr. Roger Wong with Award for Eminent Contribution to Older Adults in Canada</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YzNlOWZkNDctZThiZC00MzJjLTg2MmItM2U3ZTNhNzViYzJhLTUwMDE2MjAyOC0yMDI2LTA1LTA0LWVu/tiny/Entente-Education-Canada.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Cartesian Therapeutics Announces New Employment Inducement Grants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233626-pasithea-therapeutics-announces-appointment-of-kartik-krishnan-m-d-ph-d-as-chief-medical-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:01:00+00:00</news:publication_date>
        <news:title>Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0016f128-13c3-45a7-8455-cec1f4768995/small/pasithealogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Ardena Strengthens Executive Team to Drive its Next Phase of Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Indivior Announces $175 Million Accelerated Share Repurchase</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233623-netramark-appoints-dr-panteli-theocharous-as-fractional-chief-medical-officer-strengthening-clinical-leadership-to-accelerate-global-adoption-of</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233629-krystal-biotech-announces-first-quarter-2026-financial-and-operating-results</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Krystal Biotech Announces First Quarter 2026 Financial and Operating Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233642-10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e71b27b-1cc8-4780-8689-8d8d6ae86236/medium/clean-slate-and-salty-sips.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233645-seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233649-centrum-launches-newly-reformulated-adults-50-complete-multivitamin-with-clinically-shown-cognitive-benefits</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/395df94a-8079-4f58-9b54-df434e56ec33/medium/centrum-adults-50-complete-multivitamin.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233653-centrum-lance-sa-multivitamine-compl-te-adultes-50-nouvellement-reformul-e-avec-des-bienfaits-cognitifs-d-montr-s-cliniquement</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/abbbfaf3-e52b-413c-9ded-52f74cf50911/medium/centrum-multivitamine-complete-pour-adultes-50.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233661-genyro-announces-new-paper-demonstrating-how-sidewinder-technology-democratizes-dna-construction-at-scale-and-facilitates-ai-driven-protein-design</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346f123b-cc5d-4de0-a31f-9c4f1315c070/medium/genyro-co-founders.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233678-seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ecdddbc3-8a58-4cba-a4a1-33971e79339a/medium/anthony-bazarko.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233683-istios-health-partners-with-care-id-to-expand-national-infectious-disease-clinical-research-network</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTI0OGVmYTMtNmZkNC00ODA4LWJlNzUtNTYxODJlODcxNDBmLTEzMTYxMjEtMjAyNi0wNS0wNC1lbg==/tiny/Istios-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233687-adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233701-axsome-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1186f248-bfb6-4258-a391-f2ffd94c5d76/small/axsome-r-morpheus-logo-pos-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910233704-cabaletta-bio-announces-pricing-of-150-million-underwritten-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:35:54+00:00</news:publication_date>
        <news:title>Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910224348-aura-biosciences-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:03:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910224335-aura-biosciences-announces-ceo-transition-as-company-advances-phase-3-compass-trial-toward-enrollment-completion</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:01:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910224339-holland-bloorview-kids-rehabilitation-hospital-receives-475-000-commitment-from-td-bank-group-to-support-youth-with-disabilities</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:00:00+00:00</news:publication_date>
        <news:title>Holland Bloorview Kids Rehabilitation Hospital receives $475,000 commitment from TD Bank Group to support youth with disabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YjY1NmY0MjktNjNkNy00MjI4LTgwNDYtZWJjZmRmYTgyZmI0LTExMDQ5NDUtMjAyNi0wNS0wNC1lbg==/tiny/Holland-Bloorview-Kids-Rehabil.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910224345-scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:00:00+00:00</news:publication_date>
        <news:title>Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910220606-mother-s-day-gifting-is-changing-from-symbolic-presents-to-meaningful-relief-bob-and-brad-marks-the-occasion-with-up-to-30-off-wellness-devices</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T09:10:38+00:00</news:publication_date>
        <news:title>Mother’s Day Gifting Is Changing: From Symbolic Presents to Meaningful Relief — Bob and Brad Marks the Occasion with Up to 30% Off Wellness Devices</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b55bca4c-0fac-4226-9f7d-2e4b7b3e94e0/medium/mother-s-day-gifts-2026.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910150881-agc</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910150885-novelty-nobility-agc-biologics</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/910117015-caphra-urges-policymakers-to-expand-the-tobacco-cessation-toolkit</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T19:00:00+00:00</news:publication_date>
        <news:title>CAPHRA Urges Policymakers to Expand the Tobacco Cessation Toolkit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6dc95f2d-65fb-409f-aed4-9ebe55554004/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/909983104-northeast-ohio-medical-university-neomed-celebrates-306-new-graduates-at-commencement-ceremony</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-02T22:07:03+00:00</news:publication_date>
        <news:title>Northeast Ohio Medical University (NEOMED) Celebrates 306 New Graduates at Commencement Ceremony</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDgwNDNmM2ItZGZiNi00NTRjLTgzZTUtMDg3MjZjNjY0NGIyLTUwMDE1MDkxOS0yMDI2LTA1LTAyLWVu/tiny/Northeast-Ohio-Medical-Univers.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/909978301-memopryl-gets-reviewed-complete-formula-evaluation-of-ingredient-claims-and-side-effects-risk</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-02T21:25:47+00:00</news:publication_date>
        <news:title>MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/05/MemoPryl-Reviews.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/909972974-visiocore-claims-evaluated-the-8-second-amazonian-morning-flush-for-crystal-clear-vision-support</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-02T20:50:28+00:00</news:publication_date>
        <news:title>VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/05/VisioCore-Supplement.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://mongoliahealthcarejournal.com/article/909966566-halo-care-skin-tag-remover-claims-evaluated-the-strongest-most-effective-mole-skin-tag-corrector-serum</loc>
      <news:news>
        <news:publication>
          <news:name>Mongolia Healthcare Journal</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-02T20:14:38+00:00</news:publication_date>
        <news:title>Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole &amp; Skin Tag Corrector Serum</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/05/Halo-Care-Skin-Tag-Remover.jpg</image:loc>
        </image:image>
    </url>
</urlset>
